|
ZNF430 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.110400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.921840E-02 |
| Normal-vs-Stage2 |
9.379400E-01 |
| Normal-vs-Stage3 |
2.090800E-01 |
| Normal-vs-Stage4 |
4.015800E-01 |
| Stage1-vs-Stage2 |
1.633050E-01 |
| Stage1-vs-Stage3 |
3.747400E-01 |
| Stage1-vs-Stage4 |
2.657200E-01 |
| Stage2-vs-Stage3 |
4.159000E-01 |
| Stage2-vs-Stage4 |
6.122800E-01 |
| Stage3-vs-Stage4 |
7.807400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.318400E-02 |
| Normal-vs-AfricanAmerican |
3.221000E-01 |
| Normal-vs-Asian |
3.114400E-02 |
| Caucasian-vs-AfricanAmerican |
9.728400E-01 |
| Caucasian-vs-Asian |
2.833600E-01 |
| AfricanAmerican-vs-Asian |
4.924400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.878400E-01 |
| Normal-vs-Female |
1.553930E-02 |
| Male-vs-Female |
8.458300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.664800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.477250E-01 |
| Normal-vs-Age(61-80Yrs) |
5.545400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.288600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.523410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.765700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.423960E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.269000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.568100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.632240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.698200E-01 |
| Classical-VS-Follicular |
1.8352985797776E-11 |
| Classical-VS-Other |
2.096600E-01 |
| Classical-VS-Normal |
2.178100E-04 |
| Tall-VS-Follicular |
1.365830E-04 |
| Tall-VS-Other |
3.078400E-01 |
| Tall-VS-Normal |
1.231640E-01 |
| Follicular-VS-Other |
3.704600E-01 |
| Follicular-VS-Normal |
4.304600E-03 |
| Other-VS-Normal |
8.434000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.354200E-01 |
| Normal-vs-N1 |
2.597600E-01 |
| N0-vs-N1 |
5.632000E-01 |
|
|
